Extracorporeal Blood Purification Techniques in Septic Shock: Operating Principles, Supporting Evidence and Clinical Applications
- 1Department of Anesthesia, Intensive Care Medicine and Pain Therapy, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), 34149 Trieste, Italy
Abstract
Several extracorporeal blood purification techniques are used to treat septic shock and other conditions characterized by the release of inflammatory mediators and bacterial toxins, notably lipopolysaccharide (endotoxin), which account for the cardiovascular, coagulation and metabolic derangements. Each technique has advantages and drawbacks, including, for most devices, the need for circuit anticoagulation and the possible removal of antibiotics. High-quality randomized trials remain scarce, and their heterogeneity in populations, techniques, dose and timing, together with the enrollment of biologically unselected patients, limits firm conclusions. In this narrative review, we describe the available techniques, critically appraise the clinical evidence for each modality against the 2026 Surviving Sepsis Campaign guidelines, and outline the phenotype-guided direction of ongoing research. The 2026 Surviving Sepsis Campaign guidelines suggest against the use of blood purification techniques in adults with sepsis or septic shock (conditional recommendation, very low certainty of evidence) and, specifically, against polymyxin-B hemoperfusion (conditional recommendation, low certainty of evidence). In the phenotype-enriched Tigris trial, polymyxin-B hemoadsorption showed a high posterior probability of mortality benefit in endotoxic septic shock; given the small sample, the imprecise primary estimate and the informative prior, this promising finding requires independent confirmation. Outside clinical trials, routine blood purification is not supported.
Related
- Lung Ultrasound in Children: Principles, Techniques, and Clinical Applications.
- Extracorporeal photopheresis in BK virus infection after kidney transplantation: current evidence and emerging clinical applications
- What’s New in Hand and Wrist Arthroscopy: Indications, Techniques, and Emerging Applications
- Alternative production of Lead-203: Optimizing production, purification, and radiolabelling for enhanced theranostic applications
- High-Intensity Focused Ultrasound Technology: Physical Principles, Biological Effects, and Clinical Applications in Facial and Neck Rejuvenation
BibTeX
@article{bonsano2026extracorporeal,
title = {{Extracorporeal Blood Purification Techniques in Septic Shock: Operating Principles, Supporting Evidence and Clinical Applications}},
author = {Marco Bonsano and Barbara Iacoviello and Giorgio Berlot},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218619},
url = {https://www.mdpi.com/2077-0383/15/21/8619},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Extracorporeal Blood Purification Techniques in Septic Shock: Operating Principles, Supporting Evidence and Clinical Applications
AU - Marco Bonsano
AU - Barbara Iacoviello
AU - Giorgio Berlot
PY - 2026
DA - 2026/11/05
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218619
UR - https://www.mdpi.com/2077-0383/15/21/8619
AB - Several extracorporeal blood purification techniques are used to treat septic shock and other conditions characterized by the release of inflammatory mediators and bacterial toxins, notably lipopolysaccharide (endotoxin), which account for the cardiovascular, coagulation and metabolic derangements. Each technique has advantages and drawbacks, including, for most devices, the need for circuit anticoagulation and the possible removal of antibiotics. High-quality randomized trials remain scarce, and their heterogeneity in populations, techniques, dose and timing, together with the enrollment of biologically unselected patients, limits firm conclusions. In this narrative review, we describe the available techniques, critically appraise the clinical evidence for each modality against the 2026 Surviving Sepsis Campaign guidelines, and outline the phenotype-guided direction of ongoing research. The 2026 Surviving Sepsis Campaign guidelines suggest against the use of blood purification techniques in adults with sepsis or septic shock (conditional recommendation, very low certainty of evidence) and, specifically, against polymyxin-B hemoperfusion (conditional recommendation, low certainty of evidence). In the phenotype-enriched Tigris trial, polymyxin-B hemoadsorption showed a high posterior probability of mortality benefit in endotoxic septic shock; given the small sample, the imprecise primary estimate and the informative prior, this promising finding requires independent confirmation. Outside clinical trials, routine blood purification is not supported.
SN - 2077-0383
ER -